72 Investment Holdings LLC's Q1 2022 13F: 1 position resized, no new positions or exits

Form 13F-HR for the quarter ended Mar 31, 2022 · filed May 16, 2022 · 6 reported positions · accession 0001567619-22-010957

What changed this quarter

72 Investment Holdings LLC's changes in reported equity positions, Q1 2022
Activity Security Weight before Weight now Change Shares Shares %
Reduced ENTRADA THERAPEUTICS INC (TRDA) 7.7% 5.2% −2.5 pts −1 sh 0%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 100.0% of the equity book

No changes in the top 10 this quarter

# Security Weight before Weight now
1 PROMETHEUS BIOSCIENCES INC (RXDX) 64.8% 76.3%
2 PRAXIS PRECISION MEDICINES I (PRAX) 17.3% 11.0%
3 ENTRADA THERAPEUTICS INC (TRDA) 7.7% 5.2%
4 CARIBOU BIOSCIENCES INC (CRBU) 6.3% 4.8%
5 OMEGA THERAPEUTICS INC (OMGA) 3.5% 2.4%
6 WEWORK INC (WE) 0.2% 0.2%

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).